Day 2 of ASHG 2015 opened with a very interesting session on ASHG/ESHG Building Bridges, which focused on perceptions of clinical sequencing in the US and the EU. The 4-member panel included researchers from Columbia University, the US Food and Drug Administration (FDA), the Cyprus Institute of Neurology and Genetics and Our Lady’s Children’s Hospital,… Read article →
Posts Tagged: NGS
Are you using or planning to use RNAseq in your research? If so, please help us understand your needs! Complete the global survey on RNAseq and find out how your fellow scientists are applying RNAseq technology in their research. Take the survey!
Whether you’re studying single cell genomics, circulating tumor cells or the microbiome, analyzing single cells creates the potential for a deeper understanding of cell heterogeneity. But several challenges stand in the way of this goal, such as allelic dropout, coverage uniformity and low yield. How can you overcome these? The single cell team at QIAGEN… Read article →
DNA purification is a critical step for obtaining accurate NGS data, because the quality of your starting material determines the reliability of next-generation sequencing results and data analysis. Even the best and most robust NGS technologies can only provide reliable results if the template nucleic acid is of adequate quality and purity. DNA purity is especially important at target… Read article →
In vivo studies and in vitro apoptosis assays show that cells do not die at the same time or at the same dose of a pharmacologic agent. This cell-to-cell variability is the net result of both genetic and non-genetic events. Understanding the determinants of the variability will help us develop multi-target treatment strategies that will… Read article →